baber/WOPTO huggingface dataset:
Patent NZ-555576-A (NZ)
Title: Direct compression formulation comprising a DPP-IV inhibitor, and process for making of such
Inventor: PFEFFER SABINE
IPC: A61K9/20
Filed: 2006-01-17
Abstract: Disclosed is a compressed pharmaceutical tablet or a direct compressed pharmaceutical tablet, wherein the tablet is formed from a dispersion containing particles comprising a DPPIV inhibitor in free form or in acid addition salt form, wherein: i) at least 40% of the tablet has a particle size distribution of between 10 to 250 micrometres; and ii) the tablet has a thickness to weight ratio of from 0.002 to 0.06 mm/mg or from 0.01 to 0.03 mm/mg; and the DPP-IV inhibitor is selected from 1-{2-[(5-cyanopyridin-2-yl)amino]ethylamino} acetyl-2(S)-cyano-pyrrolidine dihydrochloride, vildagliptin, L-threo-isoleucyl thiazolidine, MK-0431, GSK23A, BMS-477118, 3-(aminomethyl)-2-isobuthyl-1-oxo-4-phenyl-1,2-dihydro-6-isoquinolinecarboxamide, and 2-{[3-(aminomethyl)-2-isobuthyl-4-phenyl-1-oxo-1,2-dihydro-6-isoquinolyl]oxy}acetamide, and optionally in any case, a pharmaceutical salt thereof. Also disclosed is a compressed pharmaceutical tablet or a direct compressed pharmaceutical tablet wherein the tablet is formed from a dispersion containing particles comprising a DPP-IV inhibitor in free form or in acid addition salt form, wherein: i) at least 40% of the tablet has a particle size distribution in the tablet is between 10 to 250 micrometres; ii) the tablet has a water content of less than 10% after 1 week at 25°C and 60% ambient humidity; iii) the tablet has a thickness to weight ratio of from 0.002 to 0.06 mm/mg; and the DPP-IV inhibitor is as defined above. Also disclosed is a process for preparing the tablets described above.
Patent NZ-565422-A (NZ)
Title: Silicone conveyor lubricant with stoichiometric amount of an acid
Inventor: MORRISON ERIC D
IPC: C10M173/02
Filed: 2006-06-16
Abstract: Disclosed is a method for lubricating the passage of a container along a conveyor, comprising providing a lubricant concentrate composition comprising i. from about 0.05 percent to about 20 percent of a water-miscible silicone material and ii. one or more acid compounds in an amount sufficient to provide at least one equivalent of available, unneutralized acid for every two equivalents of alkalinity in water used to dilute the lubricant Concentrate b. diluting the lubricant concentrate with water in a ratio of one part lubricant concentrate to 100 to 1000 parts water to form a lubricant use composition and c. applying the lubricant use composition to at least a portion of the container- contacting surface of the conveyor or to at least a portion of the conveyor-contacting surface of the container, and wherein the pH of the lubricant use composition is less than about 6.4. Also disclosed is the lubricant concentrate composition used in the method.
Patent NZ-566687-A (NZ)
Title: Method for preparing the ovulated eggs of aquatic animals for quality foodstuffs and ovulated eggs prepared using said method
Inventor: GUNTHER KOHLER ANGELA
IPC: A23L17/40
Filed: 2006-10-18
Abstract: Disclosed is a method for processing the ovulated eggs of aquatic animals into delicacy foods having the following method steps: harvesting the ovulated eggs without harmful invention on the aquatic animal, exogenous treatment of the freshly harvested, ovulated eggs in an aqueous solution using an addition of the signal transduction molecules hydrogen peroxide and/or calcium chloride also naturally occurring in the egg cell for physiological stabilization of the egg membrane by ovoperoxidase activation and subsequent preservation. Also disclosed are ovulated eggs prepared using said method.
Patent NZ-569189-A (NZ)
Title: Transporting means of a chair lift or of a cableway system
Inventor: SWITZENY KURT
IPC: B61B11/00
Filed: 2008-06-17
Abstract: A transporting means of a chair lift or of a cableway system, having a frame, which is connected to a load-bearing bar coupled to a conveying cable, having a safety bar, having a device for closing the safety bar, having an energy store, having a device for charging the energy store, and having a blocking device which prevents the energy store from being charged, it being possible for the blocking device to be activated and deactivated, opening of he safety bar being prevented in the active state of the blocking device, characterised in that the blocking device prevents the safety bar from being opened over at least part of the distance covered between its fully open position and its fully closed position.
Patent NZ-570311-A (NZ)
Title: Crystalline form of 1'-(1-methylethyl)-4'-[(2-fluoro-4-methoxyphenyl)methyl]-5'-methyl-1H-pyrazol-3'-O-BETA-D-glucopyranoside, a method for its preparation and the use thereof for preparing medicaments
Inventor: KRAEMER GERD
IPC: A61K31/7056
Filed: 2007-01-10
Abstract: Disclosed is a crystalline form of 1'-(1-methylethyl)-4'-[(2-fluoro-4-methoxyphenyl)methyl]-5'-methyl-1H-pyrazol-3'-O-b-D-glucopyranoside. Further disclosed is a pharmaceutical composition which comprises a crystalline form of the above compound. Further disclose is the use of a crystalline form of the above compound for preparing a pharmaceutical composition which is suitable for the treatment or prevention of diseases or conditions which can be influenced by inhibiting the sodium-dependent glucose cotransporter SGLT (such as a metabolic disorder selected from the group consisting of type 1 diabetes mellitus, type 2 diabetes mellitus, impaired glucose tolerance, hyperglycemia, postprandial hyperglycemia, overweight, obesity or metabolic syndrome).
Patent NZ-570731-A (NZ)
Title: Device to deliver medication with circuit producing recorded speech output and movable structure to effectuate delivery and circuit
Inventor: EDWARDS ERIC SHAWN
IPC: G16H40/60
Filed: 2007-03-28
Abstract: Disclosed is an apparatus to deliver a medicament, including a medicament delivery device (650). The apparatus includes an actuator which causes the delivery device to deliver the medication when moved, and a locking member to limit movement of the actuator. The device further includes an electronic circuit (630) that outputs a recorded speech output (644), the circuit only being actuated when the locking member or actuator is moved.
Patent NZ-572041-A (NZ)
Title: Attachment of sign panels to a support using a retaining lip, hooks through holes and a ledge to rest on
Inventor: LAWRENCE ROGER JOHN
IPC: G09F7/18
Filed: 2009-12-14
Abstract: A support 1 for at least one substantially rectangular panel comprises an elongated rigid stand 2 supporting at least one bracket 3 capable of receiving an upper edge of the panel, at least one hook 5 and at least one ledge 6 capable of supporting a lower edge of the panel. The ledge 6 is sufficiently wide to assist in preventing the panel from rotating from the rested position when the support 1 is in use. The hook(s) 5 is/are intermediate the bracket 3 and the ledge 6. The bracket(s) 3, hook(s) 5 and ledge(s) 6 in combination will support the panel on the elongated rigid stand 2.
Patent NZ-578743-A (NZ)
Title: Direct compression formulation and process
Inventor: KOWALSKI JAMES
IPC: A61K9/20
Filed: 2005-01-17
Abstract: Disclosed is a pharmaceutical composition comprising; (a) 20-35% by weight on a dry weight basis of vildagliptin (also known as (s)-1-[(3-hydroxy-1-adamantyl)amino]acetyl-2-cyano-pyrrolidine and is depicted in the drawing) in free form or in acid addition salt form; (b) 40-95% by weight on a dry weight basis of a pharmaceutically acceptable diluent; (c) 0-20% by weight on a dry weight basis of a pharmaceutically acceptable disintegrant; and optionally (d) 0.1-10% by weight on a dry weight basis of a pharmaceutically acceptable lubricant. Also disclosed is a solid dosage form and a compressed pharmaceutical tablet of vildagliptin. (62) Divided Out of 548351
Patent NZ-581282-A (NZ)
Title: INHIBITION OF TUMOR METASTASIS BY ANTI NEUROPILIN 2 (Nrp2) ANTIBODIES
Inventor: WU YAN
IPC: C07K16/28
Filed: 2007-05-17
Abstract: An anti-Nrp2B antibody that is an antagonist of Nrp2. The antibody can be used for treating cancer in a mammalian subject in particular the treatment of metastasis in a human. The antibody can be used for inhibiting lymphangiogenesis.
Patent NZ-582414-A (NZ)
Title: Methods for generating immune response using cationic-liposome-mediated nucleic acid delivery
Inventor: CHANG ESTHER H
IPC: A61K9/127
Filed: 2008-07-09
Abstract: Disclosed is the use of a ligand-targeted cationic liposome complex comprising a cationic liposome, a ligand which is an antibody or antibody fragment, one or more nucleic acid molecules encoding one or more viral proteins, and one or more nucleic acid molecules encoding one or more interleukins, wherein said antibody or antibody fragment is directly complexed with, but not chemically conjugated to, said cationic liposome, in the manufacture of an antigen presenting cell-targeted delivery medicament for use in treating a viral disease in a mammal in need thereof.
Patent NZ-586544-A (NZ)
Title: Anti-c35 antibody in combination with an ani-her2 antibody in cancer therapies and methods
Inventor: ZAUDERER MAURICE
IPC: A61P35/00
Filed: 2008-12-23
Abstract: Discloses the use of an anti-C35 antibody or antigen binding fragment thereof that specifically binds C35 and an anti-HER2 antibody or antigen binding fragment thereof that specifically binds HER2 in the manufacture of a medicament for killing a cancer cell that expresses C35 and HER2 markers. Further discloses the use of an anti-EGFR antibody or antigen binding fragment thereof that specifically binds EGFR and an anti-C35 antibody or antigen binding fragment thereof that specifically binds C35 in the manufacture of a medicament for killing a cancer cell that expresses C35 and EGFR markers. Also claims the composition comprising an anti-EGFR antibody and an anti-C35 antibody.
Patent NZ-586788-A (NZ)
Title: Improvements in heat exchangers for dispensing sub-zero beer where the cooling and beverage lines are embedded in a soild block of material having high thermal conductivity
Inventor: BAKER BENJAMIN PAUL
IPC: B67D1/08
Filed: 2009-01-02
Abstract: A heat exchanger 10 comprises a first line 11 and a second line 13 embedded in a solid block 15 of a material having a high thermal conductivity with the first line 11 in the form of a first helical coil defining a plurality of turns, and the second line 13 in the form of a second helical coil defining a plurality of turns and extending around the first coil. The angle between a plane defined by the turns of the second coil and a plane defined by the turns of the first coil is between 15 and 120 degrees.
Patent NZ-587273-A (NZ)
Title: Fertilized egg isolate for treating depression and anxiety
Inventor: BAIN JERALD
IPC: A61K35/57
Filed: 2009-01-09
Abstract: Disclosed is a fertilized egg isolate, methods for preparing the fertilized egg isolate and uses thereof for treating mental health disorders and disease or conditions mediated by or associated with one or more glutamate receptors or by the neurokinin 2 (NK2) receptor.
Patent NZ-588267-A (NZ)
Title: Multilayered polyamide tube for food packaging
Inventor: KURIU HIROKI
IPC: B32B27/32
Filed: 2009-03-26
Abstract: Disclosed is a multilayered polyamide-based tube for food packaging comprising a Layer (A), a Layer (B) and a Layer (C); the multilayered polyamide-based tube having a low-temperature shrinkage ratio of 2 to 10%, and exhibiting heat shrinkage properties and gas barrier properties; the Layer (A) containing a polyamide-based resin; the Layer (B) containing a polyolefin-based resin; and the Layer (C) that comes in contact with the packaged food, the Layer (C) being a Layer (C-1) that contains a polypropylene-based resin having a heat distortion temperature (ISO 75B-1 or ISO 75B-2) of not less than 60 degrees Celsius and a Vicat softening point of not less than 120 degrees Celsius, and that has a surface wetting tension of not less than 35 mN/m; or the Layer (C) being a Layer (C-2) that contains a linear low-density polyethylene having a density of not less than 0.92 g/cm3 but less than 0.95 g/cm3 , and that has a surface wetting tension of not less than 35 mN/m.
Patent NZ-588536-A (NZ)
Title: Adjusting a load of a power generation device to maximise power transfer or to eliminate stall
Inventor: WYMA MURRAY RAYMOND
IPC: H02J7/00
Filed: 2010-10-15
Abstract: To attain maximum and optimum power transfer from an engine driven generator to an electrical load which includes both a primary load and an energy storage load, the generator being connected to the load via a load balancing circuit, output characteristics (such as generator output frequency and RMS voltage) indicative of the stall point of the generator engine are measured. Whilst the output characteristics are tracked the load balancing circuit is adjusted to increase the load on the generator so as to determine the stall point of the engine of the generator, then the load balancing circuit is adjusted to achieve a maximum or optimum power transfer to the load on the basis of preventing the engine from reaching the determined stall point. The load may be a telecommunications base station powered by a battery which is recharged by an intermittently operated engine powered generator.
Patent NZ-589393-A (NZ)
Title: Fungicidal compositions containing azole fungicide and a pyrazole derivative
Inventor: TOBLER HANS
IPC: A01N43/56
Filed: 2008-04-23
Abstract: Disclosed is a composition suitable for control of diseases caused by phytopathogens comprising (A) a tricyclic amine derivative compound of formula I wherein R1 is difluoromethyl or trifluoromethyl and X is chloro, fluoro or bromo; and (B) at least one compound selected from an azole fungicide. Also disclosed is a method of controlling diseases on useful plants or on propagation material thereof caused by phytopathogens, which comprises applying to the useful plants, the locus thereof or propagation material thereof a composition comprising a compound of formula (I) and an azole fungicide. (62) Divided Out of 580186
Patent NZ-589851-A (NZ)
Title: Cooling and grinding lignocellulosic biomass material for enzymatic fermentation to ethanol
Inventor: MEDOFF MARSHALL
IPC: C10L5/00
Filed: 2009-07-15
Abstract: A method comprising: processing an embrittled material to make a product that is chemically different from the embrittled material, the embrittled material having been produced by treating a biomass material to embrittle the biomass material, wherein treating comprises irradiating the biomass material with electron beam irradiation, wherein treating also comprises cooling the biomass material, simultaneous grinding or comminuting while cooling the biomass may also be performed in a freeze grinding or freeze milling device, and wherein cooling is performed prior to irradiating; thereby reducing the recalcitrance of the material. The biomass material comprises a lignocellulosic material, and the method further comprises separating lignin from cellulose. Said processing of the material can further comprise contacting the material with an enzyme and/or a microorganism, or the material comprises cellulose and the method comprises utilizing an enzyme to saccharify the cellulose, the saccharified material can then be converted to a product, e.g., fermented to ethanol.
Patent NZ-591253-A (NZ)
Title: Process for producing 6-(5-ethoxy-hept-1-yl)bicyclo[3.3.0]octane-3-one and product thereof
Inventor: BURNISON CHANTAL
IPC: C07C13/26
Filed: 2011-02-18
Abstract: Disclosed herein is a process for producing 6-(5-ethoxyhept-1-yl)bicyclo[3.3.0]octan-3-one comprising the steps of: · removing chlorine atoms from 6,6-dichloro-6-(5-thoxyhept-1-yl)bicyclo[3.3.0] octan -3-one utilising zinc and an acid to produce 6-(5-ethoxyhept-1-yl)bicyclo[3.3.0]octan-3-one; · adding to the 6-(5-ethoxyhept-1-yl)bicyclo[3.3.0]octan-3-one and acid, ether to form a solution; · filtering the solution to form a filtrate; removing the solvent from the filtrate to form a residue of 6-(5-ethoxyhept-1-yl)bicyclo[3.3.0]octan-3-one; · thinning the residue with ether; · treating the thinned residue with a sodium bicarbonate solution; · separating the ether layer therefrom; and removing the solvent from the ether layer; · thus recovering 6-(5-ethoxyhept-1-yl)bicyclo[3.3.0]octan-3-one therefrom.
Patent NZ-595492-A (NZ)
Title: Improved Process for the Preparation of Lenalidomide
Inventor: GORE VINAYAK GOVIND
IPC: A61K31/45
Filed: 2010-03-01
Abstract: 595492 Disclosed herein are processes for preparing 3-(4-amino-1-oxo-1,3- dihydro-isoindol-2-yl)-piperidine-2,6-dione (I) (lenalidomide) and its intermediate 3-(1-oxo- 4-nitro-1,3-dihydro-isoindol-2-yl)-piperidine-2,6-dione, and the use of lenalidomide for reducing levels of TNF? and/or for elevating levels of adenosine 3',5'-cyclic monophosphate, and in the treatment of an autoimmune disease, an immune disease, cancer, an oncogenic, oncological or cancerous condition, undesired angiogenesis, multiple myeloma, myelodysplastic syndromes, inflammation, an inflammatory disorder or a viral infection.
Patent NZ-595681-A (NZ)
Title: Endohedral fullerenes having enclosed therein one or more ozone molecules, and their use as a uv-absorbing agent
Inventor: NASERI SARA
IPC: C01B31/02
Filed: 2010-04-14
Abstract: 595681 Disclosed are endohedral fullerenes having enclosed therein one or more ozone molecules, e.g. fullerenes selected from C60-fullerene (Buckminsterfullerene), C70-fullerene, C76-fullerene, C78-fullerene, C82-fullerene, C84-fullerene, and C120-fullerene. The application further discloses a composition comprising the endohedral fullerene and a carrier material, e.g. where the carrier material is a skin lotion, such as a skin lotion comprising L-ascorbic acid or Vitamin E. Moreover, various uses of the novel fullerenes are disclosed, e.g. for skin UV-protection; in or on the surface of sun glasses; in or on the surface of window glass; in or on the surface of textiles, fabrics, clothes, wood, paint, paper, cushions, leather, hair-care products, and plants.
Patent NZ-602884-A (NZ)
Title: Antigen-binding molecule capable of binding to two or more antigen molecules repeatedly
Inventor: IGAWA TOMOYUKI
IPC: A61K39/395
Filed: 2009-04-10
Abstract: A method for improving the pharmacokinetics of an antibody, the method comprising substituting at least one amino acid of the antibody with histidine, or inserting at least one histidine into the antibody, wherein the histidine substitution or insertion increases the KD(pH5.8)/KD(pH7.4) value, defined as the ratio of KD for the antigen at pH5.8 and KD for the antigen at pH 7.4, as compared to the KD(pH5.8)/KD(pH7.4) value before the histidine substitution or insertion.
Patent NZ-607671-A (NZ)
Title: Tape applicator
Inventor: KENYON BARTON JOHN
IPC: A61M16/00
Filed: 2012-12-24
Abstract: A breathable gas supply apparatus with integrated humidifier, the apparatus being adapted for Continuous Positive Airway Pressure treatment of Sleep Apnea. The apparatus comprises: a flow generator (50); a humidifier tank to contain water for the humidifier (150); and a non-return valve to minimize flowback of water from the humidifier tank to the flow generator
Patent NZ-613021-A (NZ)
Title: Methods for controlling pain in canines using a transdermal solution of fentanyl
Inventor: NEWBOUND GARRET CONRAD
IPC: A61K31/4468
Filed: 2012-02-08
Abstract: Provided is a transdermal solution comprising fentanyl, a penetration enhancer and a volatile liquid. A preferred solution comprises octyl salicylate as the penetration enhancer and isopropanol as the volatile liquid. The solution is for use in the control of pain in canines. Further provided are methods of administering the solution to canines.
Patent NZ-618710-A (NZ)
Title: Process for the conversion of organic material to methane rich fuel gas
Inventor: MCEWEN CRAIG STEVEN
IPC: C10G47/00
Filed: 2010-02-11
Abstract: The disclosure relates to a process for the conversion of organic material to methane rich gas. The process comprises: a) vaporising organic material in a chamber free of oxygen and mixing it with an excess amount of hydrogen gas at 450 degrees C to 650 degrees C to form a mixture. b) heating this mixture to 600 degrees C to 900 degrees C in the presence of hydrogen gas and superheated steam to form a gaseous mixture comprising methane, hydrogen and acid. c) neutralising the gaseous mixture with a base. The process may optionally proceed with a metal catalyst and occur at a process between 0 and 2 atmospheres of pressure. (FIG. 3).
Patent NZ-623080-A (NZ)
Title: Merchandiser with airflow divider
Inventor: NGUYEN KEN
IPC: A47F3/04
Filed: 2014-03-28
Abstract: 623080 A refrigerated merchandiser with an air flow divider is disclosed. The merchandiser (10) includes a case defining a product display area (116) and having a base (104), a lower flue (134), a first air passageway (148), and a second air passageway (150). The first air passageway and second air passageway are in fluid communication with the lower flue and with the product display area. A fan plenum (169) includes an airflow divider with a first wall member and a second wall member positioned to direct a first portion of the airflow to the first air passageway and a second portion of the airflow to the second air passageway.
Patent NZ-625506-A (NZ)
Title: Compositions for treatment of heart failure in dogs.
Inventor: GRMAS JERNEJ
IPC: A61K47/12
Filed: 2012-12-19
Abstract: Disclosed is a fixed dose combination comprising benazepril hydrochloride and pimobendan in a ratio of 2: 1, in the form of a bilayer tablet, wherein the benazepril layer comprises 2.5, 5 or 10 mg benazepril hydrochloride which are contained in the form of pellets, and wherein the pimobendan layer comprises 1.25, 2.5 or 5 mg pimobendan. Also disclosed is a method for treating congestive heart failure in dogs comprising administering a fixed dose combination as defined above.
Patent NZ-627370-A (NZ)
Title: Food dispenser
Inventor: LAUDENBACH ERICH
IPC: B65D83/08
Filed: 2013-02-05
Abstract: A food dispensing apparatus (1) suitable for use with a food storage means (20) and for providing a wrapped food product (22), which is at least partly covered with a wrapper or sheaf (30). Further, the food dispensing apparatus has redirecting means, e.g. rollers (4), for redirecting the wrapper (30) away from the food product in order to separate the wrapper (30) and to dispense the food product (22). Feeding means (2) transport the food product (22) for feeding the wrapped food product towards the redirecting means (4), where the food product (10) is unwrapped and dispensed (3). The apparatus also includes a proximity sensor (6) for detecting when the machine should stop dispensing the product.
Patent NZ-628213-A (NZ)
Title: Adenoviruses expressing heterologous tumor-associated antigens
Inventor: FUEYO-MARGARETO JUAN
IPC: C12N15/861
Filed: 2013-02-01
Abstract: Discloses a recombinant adenovirus having a genome comprising one or more heterologous nucleic acid sequences encoding a tumour antigen, whereby the adenovirus is Delta-24 and expresses the tumour antigen(s) on its surface.
Patent NZ-630499-A (NZ)
Title: Produce box
Inventor: BANKOWSKI PIOTR
IPC: B65D85/52
Filed: 2013-11-27
Abstract: A produce carton with air cooling openings in the face of the walls and across the scores or edges of the carton. The carton provides holes or perforations for air flow into it to keep produce at optimum humidity and temperature. The box can be either a base (12) or a lid (10) and base combination, with pairs of opposing face holes (32a, 32b) and opposing, centrally located holes which span across two faces, creating a score vent (34a) i.e. a vent that crosses a bend or fold. The vents in the lid and the base are aligned such that there are still openings into the container once the two are interlocked, joined or closed.